Download PDF
CC BY-NC-ND 4.0 · J Lab Physicians 2022; 14(03): 265-270
DOI: 10.1055/s-0042-1742419
Original Article

Frequency and Antibiotic Susceptibility of Pathogens from Cases of Urinary Tract Infection: A Prospective Observational Study

Gautam Ram Choudhary
1   Department of Urology, All India Institute of Medical Sciences, Jodhpur, India
,
Pritesh Jain 
1   Department of Urology, All India Institute of Medical Sciences, Jodhpur, India
,
Himanshu Pandey
1   Department of Urology, All India Institute of Medical Sciences, Jodhpur, India
,
Vijay Kumar Sarma Madduri
1   Department of Urology, All India Institute of Medical Sciences, Jodhpur, India
,
Mahendra Singh
1   Department of Urology, All India Institute of Medical Sciences, Jodhpur, India
,
Prateek Gupta
1   Department of Urology, All India Institute of Medical Sciences, Jodhpur, India
,
Suresh Goyal
2   Department of Urology, Guru Gobind Medical College, Faridkot, Punjab, India
,
Vibhor Tak
3   Department of Microbiology, All India Institute of Medical Sciences, Jodhpur, India
,
Vijaya Lakshmi Nag
3   Department of Microbiology, All India Institute of Medical Sciences, Jodhpur, India
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Abstract

Objectives Urinary tract infection (UTI) is one of the most common diagnoses in patients visiting urology clinics. Rampant use of empiric and inadequate doses of antibiotics leads to an increase in resistance and poses a huge financial burden. We evaluated UTI in relation to antibiotics used, frequency, susceptibility, and resistance pattern of different pathogens at a tertiary care center and made some important observations.

Methods Prospectively 729 patients diagnosed with UTI attending a urology outpatient department from July 2018 to January 2020 were managed accordingly. Antibiotics were started on the basis of urine culture and sensitivity (c/s) or empirically and changed according to subsequent urine c/s. Repeat urine c/s was performed after 5 to 7 days of starting therapy and 10 days after completion of therapy.

Results Out of 729 subjects, 417 (57.2%) were males and 312 (42.8%) were females. The most common symptom at diagnosis was dysuria 512 (70.2%), whereas 221 (30.3%) patients presented with fever. Escherichia coli was the most common organism isolated, 453 (62.1%). Among 729 patients, 239 took antibiotics without c/s report, whereas in 490 patients antibiotics were prescribed after the report. A total of 431 (59.1%) patients required one antibiotic session for clearance of pathogen, whereas 135 (18.5%) required two sessions, and three sessions were required in 66 (9%) cases. Among 239 patients whose culture came out to be positive, 145 (60.6%) were found to be resistant to the previously given antibiotic and the common pathogens isolated were E. coli (61 [42%]), Pseudomonas (28 [19.3%]), Enterococcus (22 [15.1%]), Klebsiella (14 [9.6%]), and others.

Conclusion Unchecked, rampant, and inadequate use of antibiotics leads to complicated UTI with the increasing share of Pseudomonas, Klebsiella, or other dangerous microbes, which are difficult to treat as well as pose threat in the future.

Keywords

antibiotic resistance - antibiotics - urinary tract infection

This study was carried out at the Department of Urology and Microbiology, All India Institute of Medical sciences, Jodhpur, Rajasthan, India.




Publication History

Article published online:
09 February 2022

© 2022. The Indian Association of Laboratory Physicians. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Manges AR, Johnson JR, Foxman B, O'Bryan TT, Fullerton KE, Riley LW. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. N Engl J Med 2001; 345 (14) 1007-1013
    CrossrefPubMedGoogle Scholar
  • 2 World Health Organization. Global action plan on antimicrobial resistance. 2015 . Accessed March 20, 2019: http://www.who.int/antimicrobial-resistance/publications/global-action-plan/en/
    PubMedGoogle Scholar
  • 3 Mazzulli T. Antimicrobial resistance trends in common urinary pathogens. Can J Urol 2001; 8 (Suppl. 01) 2-5
    PubMedGoogle Scholar
  • 4 Alam MF, Cohen D, Butler C. et al. The additional costs of antibiotics and re-consultations for antibiotic-resistant Escherichia coli urinary tract infections managed in general practice. Int J Antimicrob Agents 2009; 33 (03) 255-257
    CrossrefPubMedGoogle Scholar
  • 5 Kibret M, Abera B. Prevalence and antibiogram of bacterial isolates from urinary tract infections at Dessie Health Research Laboratory, Ethiopia. Asian Pac J Trop Biomed 2014; 4 (02) 164-168
    CrossrefPubMedGoogle Scholar
  • 6 Bahadin J, Teo SSH, Mathew S. Aetiology of community-acquired urinary tract infection and antimicrobial susceptibility patterns of uropathogens isolated. Singapore Med J 2011; 52 (06) 415-420
    PubMedGoogle Scholar
  • 7 Shepherd AK, Pottinger PS. Management of urinary tract infections in the era of increasing antimicrobial resistance. Med Clin North Am 2013; 97 (04) 737-757 , xii
    CrossrefPubMedGoogle Scholar
  • 8 Shlaes DM, Gerding DN, John JF. et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 1997; 25 (03) 584-599
    CrossrefPubMedGoogle Scholar
  • 9 Goossens H. Antibiotic consumption and link to resistance. Clin Microbiol Infect 2009; 15 (Suppl. 03) 12-15
    CrossrefPubMedGoogle Scholar
  • 10 Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ 2010; 340: c2096
    CrossrefPubMedGoogle Scholar
  • 11 Lammers RL, Gibson S, Kovacs D, Sears W, Strachan G. Comparison of test characteristics of urine dipstick and urinalysis at various test cutoff points. Ann Emerg Med 2001; 38 (05) 505-512
    CrossrefPubMedGoogle Scholar
  • 12 Cruickshank R, Duguid JP, Marnian BP, Swain RH. Tests for identification of bacteria. In: Cruickshank R. ed, Medical Microbiology, Vol II, 12th ELBS ed. London: Churchill Livingstone; 1975: 170-189
    Google Scholar
  • 13 Schaeffer AJ, Schaeffer EM. Infections of the urinary tract. In: Wein AJ, Kavoussi LR, Partin AW, Peters CA. eds. Campbell-Walsh Urology, 10th ed. Philadelphia, PA: WB, Saunders company; 2012: 297-300
    Google Scholar
  • 14 Smyth ET, McIlvenny G, Enstone JE. et al; Hospital Infection Society Prevalence Survey Steering Group. Four country healthcare associated infection prevalence survey 2006: overview of the results. J Hosp Infect 2008; 69 (03) 230-248
    CrossrefPubMedGoogle Scholar
  • 15 Xie DS, Xiong W, Xiang LL. et al. Point prevalence surveys of healthcare-associated infection in 13 hospitals in Hubei Province, China, 2007-2008. J Hosp Infect 2010; 76 (02) 150-155
    CrossrefPubMedGoogle Scholar
  • 16 Tandogdu Z, Cek M, Wagenlehner F. et al. Resistance patterns of nosocomial urinary tract infections in urology departments: 8-year results of the global prevalence of infections in urology study. World J Urol 2014; 32 (03) 791-801
    PubMedGoogle Scholar
  • 17 Choe HS, Lee SJ, Cho YH. et al; GPIU Asian Investigators. Aspects of urinary tract infections and antimicrobial resistance in hospitalized urology patients in Asia: 10-Year results of the Global Prevalence Study of Infections in Urology (GPIU). J Infect Chemother 2018; 24 (04) 278-283
    CrossrefPubMedGoogle Scholar
  • 18 Chu CM, Lowder JL. Diagnosis and treatment of urinary tract infections across age groups. Am J Obstet Gynecol 2018; 219 (01) 40-51
    CrossrefPubMedGoogle Scholar
  • 19 Wagenlehner FME, Cloutier DJ, Komirenko AS. et al; EPIC Study Group. Once-daily plazomicin for complicated urinary tract infections. N Engl J Med 2019; 380 (08) 729-740
    CrossrefPubMedGoogle Scholar
  • 20 Mölstad S, Erntell M, Hanberger H. et al. Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme. Lancet Infect Dis 2008; 8 (02) 125-132
    CrossrefPubMedGoogle Scholar
  • 21 Lim JM, Singh SR, Duong MC, Legido-Quigley H, Hsu LY, Tam CC. Impact of national interventions to promote responsible antibiotic use: a systematic review. J Antimicrob Chemother 2020; 75 (01) 14-29
    CrossrefPubMedGoogle Scholar
  • 22 Moet GJ, Jones RN, Biedenbach DJ, Stilwell MG, Fritsche TR. Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004). Diagn Microbiol Infect Dis 2007; 57 (01) 7-13
    CrossrefPubMedGoogle Scholar
  • 23 Chandy SJ, Thomas K, Mathai E, Antonisamy B, Holloway KA, Stalsby Lundborg C. Patterns of antibiotic use in the community and challenges of antibiotic surveillance in a lower-middle-income country setting: a repeated cross-sectional study in Vellore, South India. J Antimicrob Chemother 2013; 68 (01) 229-236
    CrossrefPubMedGoogle Scholar
  • 24 Howard P, Pulcini C, Levy Hara G. et al; ESCMID Study Group for Antimicrobial Policies (ESGAP), ISC Group on Antimicrobial Stewardship. An international cross-sectional survey of antimicrobial stewardship programmes in hospitals. J Antimicrob Chemother 2015; 70 (04) 1245-1255
    CrossrefPubMedGoogle Scholar
  • 25 Boel J, Andreasen V, Jarløv JO. et al. Impact of antibiotic restriction on resistance levels of Escherichia coli: a controlled interrupted time series study of a hospital-wide antibiotic stewardship programme. J Antimicrob Chemother 2016; 71 (07) 2047-2051
    CrossrefPubMedGoogle Scholar